Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.73
Delayed Data
As of 1:54pm ET
 -0.025 / -0.91%
Today’s Change
1.96
Today|||52-Week Range
4.55
-9.17%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.75
Today’s open2.70
Day’s range2.70 - 2.75
Volume46,476
Average volume (3 months)369,500
Market cap$90.1M
Dividend yield--
Data as of 1:54pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+32.20%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.01-0.55%
ARQLArQule Inc-0.05-4.06%
CEMIChembio Diagnostics ...-0.05-0.75%
AGLEAeglea Bio Therapeut...-0.25-4.49%
Data as of 1:53pm ET, 05/24/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts